(Q47382989)

English

The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE).

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE). (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

venous thromboembolism

1 reference

based on heuristic

inferred from title

author name string

R Barba

1

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

J Marco

2

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

H Martín-Alvarez

3

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

P Rondon

4

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

C Fernández-Capitan

5

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

F Garcia-Bragado

6

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

M Monreal

7

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

RIETE investigators

8

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

3

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

5

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

856-862

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Anticoagulant pharmacodynamics of tinzaparin following 175 iu/kg subcutaneous administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Laboratory monitoring of low-molecular-weight heparin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01304.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2005.01304.X

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

release_umyujohesbe4fgwpa3p2arrrlu

1 reference

https://api.fatcat.wiki/v0/release/umyujohesbe4fgwpa3p2arrrlu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/15869577

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47382989&oldid=1836262499"